110
Participants
Start Date
December 29, 2020
Primary Completion Date
January 26, 2024
Study Completion Date
May 29, 2024
IMCY-0098 450 μg
Small synthetic peptide for SC admin. Solvent: alum hydroxide
IMCY-0098 1350 μg
Small synthetic peptide for SC admin. Solvent: alum hydroxide
Placebo
Solvent: alum hydroxide
University of Alabama at Birmingham, Birmingham
University of Chicago, Chicago
Barbara Davis Center, Aurora
Joslin Diabetes Center, Boston
Princess Alexandra Hospital, Brisbane
Royal Melbourne Hospital, Melbourne
St. Vincent's Hospital, Melbourne
Royal North Shore Hospital, Sydney
Université Libre de Bruxelles - Hôpital Erasme - ULB, Brussels
UZ Brussels, Brussels
Katholieke Universiteit Leuven UZ Gasthuisberg, Leuven
Ospedale San Raffaele S.r.l., Milan
AOU Pisana - Ospedale Cisanello, Pisa
Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas
Klaipeda university hospital, Klaipėda
Vilnius university hospital Santaros klinikos, Vilnius
UMC - University Children's Hospital, Ljubljana
Department of clinical sciences, CRC/Malmö, Lund University, Lund
Addenbrooke's Hospital, Cambridge
University Hospital of Wales, Cardiff
Royal Infirmary of Edinburgh, Edinburgh
Royal Devon and Exeter Hospital, Exeter
St James´s University Hospital, Leeds
Leicester General Hospital, Leicester
Guy's and St Thomas' Hospital, London
Royal London Hospital, London
St George's Hospital, London
Royal Victoria Infirmary, Newcastle
Churchill Hospital, Oxford
Lead Sponsor
Imcyse SA
INDUSTRY